Description

CJC-1295 NO DAC + GHRP Blend Peptide Vials

CJC-1295 NO DAC + GHRP-2 Blend consists of 2mg CJC No Dac and 2mg GHRP-2, totaling 4mg.

CJC-1295 No DAC + GHRP-6 Blend consists of 2mg CJC No Dac and 2mg GHRP-6, totaling 4mg.

Mod grf 1-29/ CJC-1295 No DAC
CAS Number	86168-78-7
Molar Mass	3357.93 g·mol−1
Chemical Formula	C149H246N44O42S
IUPAC Name	L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide
GHRP-6
CAS Number	87616-84-0
Molar Mass	873.032 g·mol−1
Chemical Formula	C46H56N12O6
IUPAC Name	L-histidyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-Lysinamide

Introduction

CJC-1295 NO DAC + GHRP Blend Vials represent a cutting-edge research product designed exclusively for scientific investigations. Strictly intended for research purposes, these vials contain a combination of CJC-1295 (without DAC) and GHRP, two peptides known for their potential influence on growth hormone regulation.

Key Characteristics

This research product combines CJC-1295, a modified Growth Hormone Releasing Hormone (GHRH) analog, with a Growth Hormone Releasing Peptide (GHRP). The absence of DAC (Drug Affinity Complex) in CJC-1295 allows for a shorter half-life, potentially leading to more pulsatile growth hormone release when paired with GHRP.

Research Applications

CJC-1295 NO DAC + GHRP Blend Vials offer researchers a tool to explore the intricate mechanisms involved in growth hormone regulation. The combination of CJC-1295 and GHRP provides a unique avenue for investigating their synergistic effects on growth hormone release and potential applications in various physiological processes.

Research Benefits

Increased Growth Hormone Levels

Research studies have indicated that the combination of CJC-1295 NO DAC and GHRP may lead to increased growth hormone levels. This effect could be valuable for researchers studying the impact of elevated growth hormones on various physiological functions.

Normalization of Growth Hormone Levels

The blend of CJC-1295 NO DAC and GHRP has shown potential in normalizing growth hormone levels. This research application may contribute to understanding the mechanisms involved in maintaining balanced growth hormone secretion.

Positive Effects on Cardiac Function

Preliminary studies suggest that the CJC-1295 NO DAC + GHRP blend may have positive effects on cardiac function. Researchers are exploring its potential impact on cardiovascular health, providing new avenues for investigations in this field

Summary

CJC-1295 NO DAC + GHRP Blend Vials serve as a valuable tool for researchers interested in unraveling the complexities of growth hormone regulation. With its unique characteristics, this blend opens up possibilities for understanding the potential benefits of growth hormone levels and cardiovascular function.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References:

1. Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C. Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood. Clin Endocrinol (Oxf). 1995 Feb;42(2):191-4. doi: 10.1111/j.1365-2265.1995.tb01861.x. PMID: 7734029. [Read More]
2. Bowers, C.Y., Laferrére, B., Hurley, D.L., Veldhuis, J.D. (2007). The Role of Growth Hormone Secretagogues and Ghrelin in Feeding and Body Composition. In: Donohoue, P.A. (eds) Energy Metabolism and Obesity. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-139-4_8. [Read More]